StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Loan & DebtMar 29, 2026, 08:46 PM

Amgen Issues $4 Billion in Senior Notes Due 2031-2056

AI Summary

Amgen issued $4 billion in aggregate principal amount of senior notes across four tranches with maturities ranging from 2031 to 2056. The proceeds, net of discounts and expenses, totaled approximately $3.96 billion and will likely be used for general corporate purposes, including potential acquisitions, debt repayment, or share repurchases, impacting Amgen's capital structure and financial flexibility.

Key Highlights

  • Issued $1 billion of 4.200% Senior Notes due 2031.
  • Issued $1.75 billion of 4.850% Senior Notes due 2036.
  • Issued $500 million of 5.500% Senior Notes due 2046.
  • Issued $750 million of 5.650% Senior Notes due 2056.
  • Net proceeds were approximately $3.96 billion after deducting discounts and expenses.